MedCity News
OCTOBER 11, 2022
In response to emailed questions, executives from Biofourmis, Force Therapeutics and Project Ronin shared products they’re developing in remote patient monitoring as part of the broader hospital at home trend.
Medgadget
OCTOBER 11, 2022
Researchers at the University of California San Francisco have developed a suite of video games that have been designed to improve cognition in older adults who are otherwise healthy. The games aim to recreate common activities, such as banging a drum or driving a car. They also include a sophisticated algorithm that automatically adjusts the game difficulty depending on how well someone is playing, helping to stop less skilled players from becoming overwhelmed and more skilled players from beco
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
OCTOBER 11, 2022
Cybercriminals are weaponizing the same tools that healthcare providers use to operate and maintain secure IT systems, HHS warned in a recent report. Providers can protect themselves by having a firm grasp of what their IT environment looks like, as this may help them spot any suspicious security tool commands.
Medgadget
OCTOBER 11, 2022
At Johns Hopkins, clinical researchers have developed a set of surgical tools that allow them to more easily create a replacement ear for those born with malformed or missing ears. Currently, using cartilage harvested from the ribs, surgeons can create a new ear, but the process is difficult and requires some artistic talent to sculpt the cartilage into the right shape.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
MedCity News
OCTOBER 11, 2022
How do organizations optimize and scale business intelligence? Here are five basic steps to consider when developing dashboards to assess your operational, financial and quality components within the care at home industry.
pharmaphorum
OCTOBER 11, 2022
An intranasal formulation of AstraZeneca’s widely-used COVID-19 vaccine Vaxzevria has failed at the first hurdle, after results from a phase 1 trial found it was unable to stimulate a strong immune response to the virus. The 30-subject study – funded by AZ and published in the Lancet journal eBioMedicine – tested two strengths of the current formulation of the vaccine administered as a nasal spray, with half the group receiving a second intranasal dose 28 days later, and half getting a reg
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmExec
OCTOBER 11, 2022
Bristol Myers Squibb commercial head Chris Boerner believes a straightforward formula is the best formula in advancing innovation and developing talent in today’s complex healthcare climate—an approach he roots in authenticity and “not over engineering,” whether tackling business or culture.
MedCity News
OCTOBER 11, 2022
It is Mark Cuban Cost Plus Drug Company’s first collaboration with a health plan. The pharmacy company will not be replacing Capital Blue Cross’ existing pharmacy benefits manger, but instead will be an additional option for members to choose.
PharmExec
OCTOBER 11, 2022
Pharma supply chains are no longer hidden beyond the reach of ESG agendas, making it important for companies to accelerate adoption of new manufacturing processes and environmental technology.
MedCity News
OCTOBER 11, 2022
Almost 40% of employers made changes to their retiree healthcare benefits in the last three years, while another 63% plan to in the next three three years, the Willis Towers Watson survey found. Some are looking to replace their traditional group plan offerings with individual insurance through a private marketplace.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
pharmaphorum
OCTOBER 11, 2022
An explosion of digital mental health tools being offered for sale has presented regulators with a problem – how should they be classified and assessed for safety or efficacy? Wellcome has provided funding in the UK to help answer that question. The healthcare charity is providing £1.8 million (around $2 million) in financial support for UK health technology assessment (HTA) agency NICE and medicines regulator MHRA to develop guidance on “appropriate, risk-proportionate regulation of digit
MedCity News
OCTOBER 11, 2022
Dice Therapeutics reported the first human data for its oral psoriasis drug designed to hit the same pro-inflammatory protein blocked by blockbuster antibody drugs from Novartis and Eli Lilly. The potential for Dice’s pill to offer a competitive oral alternative pushed the biotech’s stock skyward by nearly 80%.
Impetus Digital
OCTOBER 11, 2022
A version of this article was previously published on PharmaPhorum. By now, we’re all (hopefully) getting accustomed to the concept of “patient-centricity.” However, another commonly overlooked but equally important group of healthcare stakeholders is caregivers. These are people–mostly women–who dedicate themselves to supporting the patient throughout their disease or treatment journey.
MedCity News
OCTOBER 11, 2022
A look at how tapping real world evidence from medical devices and patients could be a game changer, improving patient-clinician communication, supporting earlier interventions and helping patients manage their condition.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
PharmaVoice
OCTOBER 11, 2022
After making the leap from academia to the world of biotech, CEO Dr. Amit Etkin is hoping to shift the treatment paradigm for neurological conditions.
MedCity News
OCTOBER 11, 2022
A bill mandating electronic prior authorization for Medicare Advantage plans has passed the House of […].
MedReps
OCTOBER 11, 2022
Nurses seemingly have a leg up when it comes to branching into medical sales. After all, they have plenty of medical knowledge and know what certain medications do, which devices to reach for in certain circumstances and more. However, is it really that easy to go from one job to another? After all, medical sales seem like a very different animal from nursing.
European Pharmaceutical Review
OCTOBER 11, 2022
The Pistoia Alliance, a non-profit advocating R&D collaboration in life sciences, has launched the Clinical Trials Environmental Impact Community of Interest (CoI) , a collaborative initiative that aims to calculate the carbon footprint of centralised and decentralised clinical trials, enabling a standard that companies can use to calculate a clinical trial’s carbon impact.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
pharmaphorum
OCTOBER 11, 2022
As the Frontiers Health 2022 conference in Milan on 20th to 21st October draws ever nearer, pharmaphorum has been catching up with members of the event’s Steering Committee to find out more about what drives both them and the event itself. This time, Paul Tunnah – pharmaphorum’s very own founder and chief content officer and managing director UK at Healthware Group – discussed healthcare’s digital transformation (this year’s guiding theme) and his own journey into the digital space.
European Pharmaceutical Review
OCTOBER 11, 2022
The study produced by the University of Cambridge has indicated that pharmaceutical companies are increasingly leaning away from one-time transactions with contract research organisations (CRO), to preferred providers and multi-year strategic partnerships. Using survey data, the research identified that 25 percent of outsourced projects are contracted to transactional service providers, 50 percent are conducted with preferred providers and the remaining 25 percent are managed through strategic p
Pharma Pathway
OCTOBER 11, 2022
Indoco Remedies Ltd.-Walk-In Interviews for Quality Assurance /QC/ Production/ Packing On 14th Oct’ 2022. Job Description. Walk-In Interviews for Quality Assurance /QC/ Production/ Packing On 14th Oct’ 2022 @ Indoco Remedies Ltd. Company Name: Indoco Remedies Ltd. Department: Quality Assurance (AQA) /QC/ Production/ Packing. Qualification: B.Pharma/ B.Sc/ M.Sc/ ITI/ 10+2.
PharmaTimes
OCTOBER 11, 2022
Therapy demonstrates significantly accelerated insulin absorption and early exposure
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Map My Customers
OCTOBER 11, 2022
There’s no doubt that the business environments we operate in now are digital-heavy and packed with more-informed consumers. That is why one of the most essential weapons of today’s successful sales teams is sales software. So, if your team is not optimizing their effectiveness through the use of technology, they will be left behind by the competition that is.
PharmaTimes
OCTOBER 11, 2022
Data from the study shows that ACD856 has a potential neuroprotective effect in a cellular mode
PharmaVoice
OCTOBER 11, 2022
CEO Leonard Mazur explains how the company’s hoping to unlock the potential of its varied pipeline.
PharmExec
OCTOBER 11, 2022
Big pharma’s finicky appetite for M&A comes as valuations of sellers soften. Though the pace of deals has picked up some, predicting just how long both sides will hold tight remains difficult.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmaceutical Technology
OCTOBER 11, 2022
Swiss biotech company Stalicla has signed a licensing deal with Evgen Pharma for the latter’s lead asset, SFX-01, in neurodevelopmental disorders and schizophrenia. Under the deal, Stalicla will gain the global rights of SFX-01 as a potential treatment for autism spectrum disorder (ASD), while Evgen will retain SFX-01’s worldwide rights for all other indications.
Scott’s Directories
OCTOBER 11, 2022
The healthcare sector is becoming more attractive in terms of investment for B2C and B2B companies as the sector is increasingly expanding. While other sectors show expansion and contraction phases as they follow general market trends, the healthcare sector doesn’t. It guarantees insignificant loss and stable growth as it positions itself against market trends regardless of the phase.
Evolve Your Success
OCTOBER 11, 2022
Those not that well-versed in medical sales tend to confuse a sales representative with a clinical specialist. They may be working hand-in-hand, but their responsibilities largely differ from each other. Shedding light on this with Samuel Adeyinka is Holly Frankenberg , who provides a glimpse into her career as a clinical pain specialist. Holly talks about the necessary characteristics to succeed in this position, her experiences working with sales reps and other healthcare providers, her bigge
LEVO Health
OCTOBER 11, 2022
With approximately 61 million Americans living with a disability and attention spans getting shorter, it’s more crucial than ever for healthcare organizations to have an accessible ADA-compliant website. If your website is user-friendly and accessible, you’re more likely to engage potential patients, leading to increased conversions and ROI.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
129 
Let's personalize your content